Showing results (171-180 of 436) with videos related to
Sort By:
Pageof 44
Clinical Trials (London, England)|March 27, 2013
Early phase trial design for assessing several dose levels for toxicity and efficacy for targeted agentsAntje Hoering, Alan Mitchell, Michael LeBlanc, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2007
Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implicationsRonald Walker, Bart Barlogie, Jeffrey Haessler, et al.British Journal of Haematology|June 27, 2007
Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3Bart Barlogie, Elias Anaissie, Frits van Rhee, et al.Cancer Nursing|October 10, 2009
Initial report of a family registry of multiple myelomaElizabeth Ann Coleman, Henry Lynch, Carol Enderlin, et al.Blood|February 17, 2007
CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanismsFenghuang Zhan, Simona Colla, Xiaosong Wu, et al.International Journal of Environmental Research and Public Health|July 2, 2021
Socioeconomic Inequities in Youth Participation in Physical Activity and SportsPooja S Tandon, Emily Kroshus, Katharine Olsen, et al.Medrxiv : the Preprint Server for Health Sciences|October 27, 2020
Association between live childhood vaccines and COVID-19 outcomes: a national-level analysisChikara Ogimi, Pingping Qu, Michael Boeckh, et al.Epidemiology and Infection|March 16, 2021
Association between live childhood vaccines and COVID-19 outcomes: a national-level analysisChikara Ogimi, Pingping Qu, Michael Boeckh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2005
Avascular necrosis of femoral and/or humeral heads in multiple myeloma: results of a prospective study of patients treated with dexamethasone-based regimens and high-dose chemotherapyGiampaolo Talamo, Edgardo Angtuaco, Ronald C Walker, et al.Genes, Chromosomes & Cancer|April 3, 2008
Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumorsAna Gabrea, Maria Luisa Martelli, Ying Qi, et al.Pageof 44